Susquehanna Fundamental Investments, LLC Gilead Sciences, Inc. Transaction History

Susquehanna Fundamental Investments, LLC

$4.33 Trillion
Q2 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 16, 2023	SELL	$77.31 - $88.08 $3.93 Million - $4.48 Million	-50,885 Reduced 30.75%	114,568 $9.51 Million
Q4 2022 Feb 14, 2023	SELL	$62.32 - $89.47 $11.1 Million - $16 Million	-178,817 Reduced 51.94%	165,453 $14.2 Million
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $14.8 Million - $16.9 Million	249,175 Added 262.03%	344,270 $21.2 Million
Q4 2021 Feb 14, 2022	SELL	$64.88 - $73.64 $527,604 - $598,840	-8,132 Reduced 7.88%	95,095 $6.91 Million
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $4.16 Million - $4.49 Million	61,427 Added 146.95%	103,227 $7.21 Million
Q2 2021 Aug 11, 2021	BUY	$63.47 - $69.35 $2.65 Million - $2.9 Million	41,800 New	41,800 $2.88 Million
Q3 2020 Nov 16, 2020	SELL	$62.1 - $78.08 $2.58 Million - $3.25 Million	-41,600 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$72.34 - $84.0 $2.07 Million - $2.4 Million	28,600 Added 220.0%	41,600 $3.2 Million
Q1 2020 May 15, 2020	SELL	$62.63 - $80.22 $513,378 - $657,563	-8,197 Reduced 38.67%	13,000 $972,000
Q4 2019 Feb 14, 2020	SELL	$61.62 - $67.78 $110,916 - $122,004	-1,800 Reduced 7.83%	21,197 $1.38 Million
Q3 2019 Nov 14, 2019	BUY	$62.51 - $69.0 $799,940 - $882,993	12,797 Added 125.46%	22,997 $1.46 Million
Q2 2019 Aug 14, 2019	SELL	$61.87 - $69.38 $5.24 Million - $5.88 Million	-84,700 Reduced 89.25%	10,200 $689,000
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $2.16 Million - $2.42 Million	34,600 Added 57.38%	94,900 $6.17 Million
Q4 2018 Feb 14, 2019	BUY	$60.54 - $79.0 $3.65 Million - $4.76 Million	60,300 New	60,300 $3.77 Million
Q2 2018 Aug 14, 2018	SELL	$64.88 - $75.68 $4.78 Million - $5.58 Million	-73,700 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$72.84 - $88.8 $5.37 Million - $6.54 Million	73,700 New	73,700 $5.56 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.2 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.09 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.72 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.57 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.

Account